Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Vectura to develop digitally-connected inhalers

Will collaborate with Propeller Health on sensor-enabled devices

Propeller Health digital sensor asthma COPD 

Vectura is working on a range of digitally-connected inhalers to help patients with respiratory diseases more engaged with their care.

It is collaborating with Propeller Health on the devices, which it also hopes will better equip patients to understand their disease and improve self-management.

The new inhalers will combine elements of Vectura's GyroHaler with an FDA-approved add-on senor from Propeller health (whose technology is pictured).

The companies are also discussing additional connected strategies for other proprietary respiratory devices in Vectura's pipeline.

James Ward-Lilley CEO, Vectura, said: “Adherence to therapy is one of the major issues driving poor maintenance management of these chronic conditions. 

“There is increasing evidence of the value of intelligent sensor technology significantly enabling a reduction of symptoms, including exacerbations and long term healthcare utilisation costs. This collaboration is a first step towards Vectura embracing a connected solution for all our devices.”

Propeller's digital health platform for asthma and chronic obstructive pulmonary disease (COPD) is currently used by more than 40 leading healthcare organisations across the US.

David Van Sickle, CEO, Propeller Health, said: “Digital health has the potential to make respiratory therapies more personal, powerful and convenient for every patient. We are excited to work with the team at Vectura to realize these benefits in a new generation of inhalers”

The firm's existing pharma deals include one with Boehringer Ingelheim, which it signed earlier this year and which targets adherence and care management for people living with asthma and COPD.

26th May 2016

From: Healthcare

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...